CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Support repeal of medical device tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN | — |
| TODD E GILLENWATER | — |
Copyright/Patent/Trademark CPT
Address concerns with provisions of patent litigation reform, including inter partes review. Educate on Bayh-Dole Act "march-in" provision.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN | — |
| TODD E GILLENWATER | — |
Health Issues HCR
FDA review process consistency and predictability. Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs. Support the Strengthening Public Health Emergency Response Act.Support the Strengthening Public Health Emergency Response Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN | — |
| TODD E GILLENWATER | — |
Medicare/Medicaid MMM
Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs, and Hospital Outpatient Prospective Payment System. Address concerns with Medicaid coverage of specialty drugs. Support creation of incentives for antibiotics development. Oppose changes to Medicare Advantage and Part D prescription drug benefit. Support the Ensuring Patient Access to Critical Breakthrough Products Act. Support Medicare Continuous Glucose Monitor Access Act. Support the Ensuring Patient Access to Critical Breakthrough Products Act. Support Medicare Continuous Glucose Monitor Access Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN | — |
| TODD E GILLENWATER | — |
Budget/Appropriations BUD
Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpile funding and preparation;FDA Appropriations; PTO Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN | — |
| TODD E GILLENWATER | — |
Medical/Disease Research/Clinical Labs MED
Support NIH research funding. Support Rare Disease Priority Review Voucher permanent extension. Support reforms to reduce administrative & regulatory burdens on scientific productivity, innovation & collaboration. Support reforms to support & evolve the scientific workforce continuum. Support 21st Century Cures Act. Support Removing Barriers to Clinical Research Act. Support Advancing Breakthrough Medical Devices for Patients Act. Support Innovation for Healthier Americans initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| MEGHAN DRENAN | — |
| TODD E GILLENWATER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.